what does glp 1 treat GLP-1 Receptor Agonists and Research to Overeating and Substance Use Disorders GLP-1R Agonists for Weight Loss

Endocr Rev 41(3)

[19] [20] Whilst some evidence supports probiotic use for specific conditionssuch as antibiotic-associated diarrhoea or certain types of irritable bowel syndromethe quality and strength of evidence varies considerably between different strains and formulations

The aim of this review is to synthesise current evidence, highlight guideline evolution, and outline practical strategies for risk assessment and management

According to FDA prescribing information, these include: Nausea (occurring in 1544% of patients depending on the specific agent and dose) Vomiting (524% of patients) Diarrhea (821% of patients) Constipation (1024% of patients) Abdominal pain or discomfort (514% of patients) These symptoms typically emerge during dose initiation or escalation and often diminish over several weeks as the body adapts

Publisher | Google Scholor Kimura I, Inoue D, Hirano K, Tsujimoto G

Noom replaces Ro Body at #2 for its best-in-class app experience and brand-name tirzepatide access